We contribute to improving the prevention and treatment of diseases that threaten global health
The prevalence of cardiometabolic diseases has increased by more than 26% in the past 10 years
Today, more than 500 million people live with genetic and lifestyle-related cardiometabolic diseases such as diabetes, obesity and cardiovascular disease.
People do not have equal opportunities for a healthy life and treatment
Rising inequity in health is not just a problem for individuals but is also a great burden for families and society.
Every year about 1.3 million people die from multidrug-resistant infections
We urgently need to improve our international preparedness for effectively managing antimicrobial resistance and novel viruses.


Our grants
The Novo Nordisk Foundation awards grants based on applications in open competition and supports a large number of different areas within health, sustainability and life science.
Projects and initiatives we have supported
Would you like to read more about the Novo Nordisk Foundation's 2030 strategy?
Towards 2030, we will increase our efforts towards solving urgent and global societal challenges. We have three focus areas.Impact
We continually measure the societal effect of our projects and initiatives.Health-related news

Researcher receives prize for huge contribution to modern treatment of diabetes and obesity

New prize awarded to researcher for improving the understanding of the genetic component of obesity
